Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapies
Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy in terms of clinical features, underlying pathogenesis and treatment outcomes. Recent advances in genomic techniques have unraveled the mo...
Source: Journal of Biomedical Science - Category: Biomedical Science Authors: Hsin-An Hou and Hwei-Fang Tien Tags: Review Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Biomedical Science | Cancer & Oncology | Hematology | Leukemia | Science